Amigo Mobility International, Inc.

Form 483 issued February 5, 2026

Inspection
Feb 2 – Feb 5, 2026
Investigator
David Gasparovich
Observations
6
Pages
7
FEI number
1821729

In short: On February 5, 2026, FDA issued a Form 483 with 6 observations to Amigo Mobility International, Inc. (FEI 1821729) after an inspection that ran Feb 2 – Feb 5, 2026. The investigator was David Gasparovich. Most observations concern cAPA and management controls.

At a glance

CAPA and management controls account for 4 of 6 observations.

CAPA2
Management controls2
Design controls1
Production & process controls1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    One or more processes for risk management in product realization have…

  2. 02

    Corrective action procedures defining the requirements for determining the causes of nonconformities and reviewing the effectiveness…

  3. 03

    Nonconforming product was not adequately evaluated to determine the need for an investigation and notification of…

  4. 04

    Process(es) for establishing competence, providing needed training and ensuring personnel awareness have…

2 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Amigo Mobility International, Inc.?

FDA listed 6 observations on this Form 483, mostly about cAPA, management controls and design controls. The opening words of each observation are shown on this page.

Who inspected Amigo Mobility International, Inc.?

David Gasparovich is named on this Form 483, for the inspection of Feb 2 – Feb 5, 2026. Each investigator has a profile showing what they cite most.

When was Amigo Mobility International, Inc. inspected by FDA?

The inspection ran Feb 2 – Feb 5, 2026, and the Form 483 is dated February 5, 2026.

How do I get the full Form 483 for Amigo Mobility International, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free